日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aberrant oxidative metabolism selects for TET2 -deficient hematopoietic stem and progenitor cells

异常的氧化代谢会筛选出TET2缺陷的造血干细胞和祖细胞。

Niño, Katia E; Adema, Vera; Gray, Alyx E; Cowan, Courtney M; Schleicher, Wolfgang E; Hosseini, Mohsen; Bennett, Sierra N; Patel, Sweta B; Moreira, Steven; Danis, Etienne; Ma, Feiyang; Lin, Hsin-Ying; Young, Tracy N; Anderson, Colin A; Sharma, Devyani; Varesi, Angelica; Filippi, Marie-Dominique; Ito, Keisuke; Dawlaty, Meelad M; Huang, Gang; Reisz, Julie A; Xie, Stephanie Z; Chan, Steven M; Tan, Lin; Garcia-Manero, Guillermo; Chien, Kelly; Gomez, Irene Gañan; D'Alessandro, Angelo; Colla, Simona; Pietras, Eric M

Risk Factors for Prognosis of Lung Cancer Patients Receiving Anlotinib Treatment: A Retrospective Cohort Study

接受安罗替尼治疗的肺癌患者预后风险因素:一项回顾性队列研究

Xie, Congyi; Chen, Jinzhan; Yang, Shuwen; Ye, Feiyang; Lin, Zhenyang; Xu, Yijiao; Yang, Yimin; Tong, Lin

Analysis of the components of Mycobacterium tuberculosis heat-resistant antigen (Mtb-HAg) and its regulation of γδ T-cell function

结核分枝杆菌耐热抗原(Mtb-HAg)成分分析及其对γδT细胞功能的调控

Jing Wei, Fangzheng Guo, Yamin Song, Tong Feng, Ying Wang, Kun Xu, Jianhan Song, Eldana Kaysar, Reyima Abdukayyum, Feiyang Lin, Kangsheng Li, Baiqing Li, Zhongqing Qian, Xiaojing Wang, Hongtao Wang, Tao Xu

Association between albumin-to-globulin ratio and the risk of overall survival in advanced non-small cell lung cancer patients with anlotinib treatment: a retrospective cohort study

白蛋白/球蛋白比值与接受安罗替尼治疗的晚期非小细胞肺癌患者总生存风险之间的关联:一项回顾性队列研究

Chen, Jinzhan; Xie, Congyi; Yang, Yimin; Yang, Shuwen; Huang, Jinxian; Ye, Feiyang; Lin, Zhenyang; Tong, Lin; Liu, Jiaxin